ObjectivesThe purpose of this study was to investigate the efficacy of tylvalosin (Aivlosin Water Soluble Granules, ECO Animal Health) in drinking water for control of Mycoplasma hyopneumoniae (M hyo) on a farm with chronic enzootic pneumonia (EP) problems and high prevalence of mycoplasma-like lesions at slaughter.DesignOn a 4000-sow farm in the southeast of Spain, 1500 animals of same age were randomly divided into two groups: 900 pigs in the treated group (TG) and 600 pigs in the non-treated control group (CG). TG was medicated for seven days with tylvalosin in drinking water (2.5 mg tylvalosin/kg bodyweight (BW)) at weaning (from 21st to 28th day of life) and a second treatment when moved to finisher barn (from 63rd to 70th day of life).ResultsIn the TG, there was a significant reduction in the severity (P<0.001) and number of animals with lung lesions (P<0.001) compared with CG. TG had an increased average daily gain and decreased average number of days in finishing. TG had a lower average carcase weight, but improved homogeneity. M hyo was not detected by q-PCR in samples, taken from lungs with characteristic EP lesions in the TG (0/9), in contrast to the CG (8/9 positive).ConclusionsA strategic medication with Aivlosin at 2.5 mg tylvalosin/kg BW in drinking water for seven days at weaning and when moved to finisher barn significantly reduces mycoplasma-like lung lesions and improves productivity parameters.
Swine dysentery causes severe economic losses in swine industry. Eliminating the disease at farm level can become problematic when resistance of the causative agent, Brachyspira hyodysenteriae, against pleuromutilins is reported. In this study, the use of tylvalosin (Aivlosin®) in eliminating the disease in a single-site, farrow-to-finish herd was evaluated. In addition, productivity parameters and antimicrobial use were compared prior to and after implementing the elimination protocol. On a mixed farm of 200 sows and 1500 finishers with a history of chronic dysentery, the B. hyodysenteriae isolate was resistant to pleuromutilins but had a low minimum inhibitory concentration for tylvalosin (2 μg/ml). Combined with a strict program for rodent control and hygiene, sows were treated with tylvalosin at a dose of 4.25 mg/kg BW daily for four weeks. The sows were washed one week after the start of the treatment before entering a clean stable. Piglets born from sows that had received this treatment, were considered free from dysentery and were kept separated from infected, untreated animals on the farm. A monitoring program with monthly sampling of sows and fatteners was installed to evaluate the absence of B. hyodysenteriae on the farm. After treatment, the clinical symptoms in the treated sows disappeared and remained absent in the offspring born after the procedure. Fecal samples examined by PCR remained negative for the whole testing period (14 months after the end of the treatment) and no clinical outbreaks were reported afterwards. The feed conversion ratio improved by 12%, the mortality rate with 37% and the antimicrobial use decreased by 71.5%. We conclude that the elimination of swine dysentery on a single-site, farrow-to-finish herd is possible using tylvalosin (AivlosinR) combined with strict hygiene and rodent control. The improvements of the technical parameters in this study are not only the result of the elimination of B. hyodysenteriae, but also changes in management practices influenced these parameters.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.